Patents by Inventor Kelly Warfield

Kelly Warfield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EBOLA MONOCLONAL ANTIBODIES
    Publication number: 20170183396
    Abstract: The present disclosure provides antibodies, and antigen-binding fragments thereof that bind to EBOV glycoprotein. The present disclosure further provides hybridoma cell lines and methods for making and using the compositions provided herein.
    Type: Application
    Filed: February 19, 2015
    Publication date: June 29, 2017
    Inventors: Jody BERRY, Grant MCCLARTY, Kelly WARFIELD, Mohammad Javad AMAN
  • Antibacterial compounds
    Patent number: 9623016
    Abstract: Provided are iminosugars having antibacterial properties and methods of treating and/or preventing bacterial infections with such iminosugars. The present disclosure relates to antibacterial compounds and, in particular, to iminosugars having antibacterial activity. One embodiment is a method of treating or preventing a bacterial infection comprising administering to a subject in need thereof an antibacterial effective amount of a compound of the following formula: or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: April 18, 2017
    Assignee: EMERGENT VIROLOGY LLC
    Inventors: Urban Ramstedt, Kelly Warfield
  • ANTIBACTERIAL COMPOUNDS
    Publication number: 20160000767
    Abstract: Provided are iminosugars having antibacterial properties and methods of treating and/or preventing bacterial infections with such iminosugars. The present disclosure relates to antibacterial compounds and, in particular, to iminosugars having antibacterial activity. One embodiment is a method of treating or preventing a bacterial infection comprising administering to a subject in need thereof an antibacterial effective amount of a compound of the following formula: or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 7, 2016
    Applicant: Unither Virology, LLC
    Inventors: Urban Ramstedt, Kelly Warfield
  • Activation of natural killer (NK) cells and methods of use
    Publication number: 20060099609
    Abstract: The present invention relates to filovirus VLPs and their use in activating innate immunity, specifically natural killer cells, and in enhancing an immune response to an antigen in an animal.
    Type: Application
    Filed: April 13, 2005
    Publication date: May 11, 2006
    Inventors: Sina Bavari, Kelly Warfield
  • Generation of virus-like particles and use as panfilovirus vaccine
    Publication number: 20060099225
    Abstract: In this application are described filovirus-like particles for both Ebola and Marburg and their use as a diagnostic and therapeutic agent as well as a filovirus vaccine. Also described is the association of Ebola and Marburg with lipid rafts during assembly and budding, and the requirement of functional rafts for entry of filoviruses into cells.
    Type: Application
    Filed: April 13, 2005
    Publication date: May 11, 2006
    Inventors: Sina Bavari, M. Aman, Kelly Warfield
  • Generation of virus-like particles and use as panfilovirus vaccine
    Publication number: 20050266023
    Abstract: In this application are described filovirus-like particles for both Ebola and Marburg and their use as a diagnostic and therapeutic agent as well as a filovirus vaccine. Also described is the association of Ebola and Marburg with lipid rafts during assembly and budding, and the requirement of functional rafts for entry of filoviruses into cells.
    Type: Application
    Filed: April 13, 2005
    Publication date: December 1, 2005
    Inventors: Sina Bavari, M. Aman, Alan Schmaljohn, Kelly Warfield, Dana Swenson